PRR18: A Potential Drug Target and Biomarker (G285800)

Target Name: PRR18

NCBI ID: G285800

PRR18

PRR18: A Potential Drug Target and Biomarker

Proline-rich repeat 18 (PRR18) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the development and maintenance of tissues. PRR18 has also been shown to be involved in the regulation of pain perception and the modulation of inflammation.

Recent studies have suggested that PRR18 may be a drug target with potential for the treatment of various diseases. One potential mechanism by which PRR18 could be targeted is through its role in pain signaling. PRR18 has been shown to be involved in the regulation of pain perception and in the modulation of pain-related signaling pathways. Therefore, drugs that can modulate PRR18 activity may have therapeutic benefits for the treatment of pain conditions such as neuropathic pain and chronic pain.

Another potential mechanism by which PRR18 could be targeted is through its role in inflammation. PRR18 has been shown to be involved in the regulation of inflammation and has been implicated in the development of various inflammatory diseases. Therefore, drugs that can modulate PRR18 activity may have therapeutic benefits for the treatment of inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease, and cancer.

In addition to its potential therapeutic benefits, PRR18 has also been shown to be a potential biomarker for a variety of diseases. The expression of PRR18 has been observed in a variety of disease states, including neurodegenerative diseases, autoimmune diseases, and cancer. Therefore, PRR18 may be a useful biomarker for the diagnosis and monitoring of these diseases.

Overall, PRR18 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its function and to develop effective treatments for the treatment of these conditions.

Protein Name: Proline Rich 18

The "PRR18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets